Shea M E, Hiasa H
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
J Biol Chem. 1999 Aug 6;274(32):22747-54. doi: 10.1074/jbc.274.32.22747.
Collisions between replication forks and topoisomerase-drug-DNA ternary complexes result in the inhibition of DNA replication and the conversion of the normally reversible ternary complex to a nonreversible form. Ultimately, this can lead to the double strand break formation and subsequent cell death. To understand the molecular mechanisms of replication fork arrest by the ternary complexes, we have investigated molecular events during collisions between DNA helicases and topoisomerase-DNA complexes. A strand displacement assay was employed to assess the effect of topoisomerase IV (Topo IV)-norfloxacin-DNA ternary complexes on the DnaB, T7 gene 4 protein, SV40 T-antigen, and UvrD DNA helicases. The ternary complexes inhibited the strand displacement activities of these DNA helicases. Unlike replication fork arrest, however, this general inhibition of DNA helicases by Topo IV-norfloxacin-DNA ternary complexes did not require the cleavage and reunion activity of Topo IV. We also examined the reversibility of the ternary complexes after collisions with these DNA helicases. UvrD converted the ternary complex to a nonreversible form, whereas DnaB, T7 gene 4 protein, and SV40 T-antigen did not. These results suggest that the inhibition of DnaB translocation may be sufficient to arrest the replication fork progression but it is not sufficient to generate cytotoxic DNA lesion.
复制叉与拓扑异构酶-药物-DNA三元复合物之间的碰撞会导致DNA复制受到抑制,并使通常可逆的三元复合物转变为不可逆形式。最终,这可能导致双链断裂的形成以及随后的细胞死亡。为了了解三元复合物导致复制叉停滞的分子机制,我们研究了DNA解旋酶与拓扑异构酶-DNA复合物碰撞过程中的分子事件。采用链置换分析来评估拓扑异构酶IV(Topo IV)-诺氟沙星-DNA三元复合物对DnaB、T7基因4蛋白、SV40 T抗原和UvrD DNA解旋酶的影响。三元复合物抑制了这些DNA解旋酶的链置换活性。然而,与复制叉停滞不同的是,Topo IV-诺氟沙星-DNA三元复合物对DNA解旋酶的这种普遍抑制并不需要Topo IV的切割和重连活性。我们还研究了这些DNA解旋酶与三元复合物碰撞后三元复合物的可逆性。UvrD将三元复合物转变为不可逆形式,而DnaB、T7基因4蛋白和SV40 T抗原则不会。这些结果表明,抑制DnaB移位可能足以阻止复制叉的前进,但不足以产生细胞毒性DNA损伤。